- Enrolling by invitationPHASE2, PHASE3
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
This study looks at a new medicine called DISC-1459 (Bitopertin) for people with Erythropoietic Protoporphyria (EPP). It's an ongoing study to see if the medicine is safe, well-tolerated, and effective over a long time for those who have already tried it in earlier studies.
For: Erythropoietic ProtoporphyriaUnited States · Australia · France - Active not recruitingPHASE3
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
This study is looking into a new medication called bitopertin for people with EPP or XLP. Researchers want to see if it's safe and helps people spend more time in the sun without pain, and how it affects certain blood chemicals.
For: Erythropoietic Protoporphyria (EPP) · X-Linked Protoporphyria (XLP)United States · Australia · Belgium